NEW YORK, Feb. 1 -- The Muscular Dystrophy Association issued the following news release on Jan. 30, 2024:

The Muscular Dystrophy Association (MDA) today announced Jeffrey Chamberlain, Ph.D., a leading professor in gene therapy focused on Duchenne muscular dystrophy (DMD) at the Institute for Stem Cell and Regenerative Medicine at the University of Washington, will receive the 2024 MDA Legacy Award for Achievement in Research, for his achievements in translational research.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products